LOUVENIA D BARKSDALE SICKLE CELL ANEMIA FOUNDATIO (EIN 570681682) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1974

Legal Domicile

Tax Period

2023-01-01 to 2023-12-31

LOUVENIA D BARKSDALE SICKLE CELL ANEMIA FOUNDATIO, founded in 1974, is a small nonprofit in the Diseases & Disorders sector that reported $621K in total revenue in fiscal year 2023. Revenue decreased 8% compared to the prior year. The organization ran a surplus of $126K, a strong 20% operating margin.

Mission

THE MISSION OF THE L.D. BARKSDALE SICKLE CELL ANEMIA FOUNDATION IS TO OPTIMIZE THE QUALITY OF HEALTH CARE AND THE QUALITY OF LIFE FOR INDIVIDUALS AND FAMILIES IMPACTED BY THE PRESCENCE OF THE SICKLE CELL DISEASE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $621,083

Program Service Revenue $0

Investment Income $15

Other Revenue $0

TOTAL REVENUE $621,098

Expense Breakdown

Grants Paid $0

Salaries & Benefits $263,137

Fundraising Expenses $0

Program Expenses $363,660

Other Expenses $231,571

TOTAL EXPENSES $494,708

Year-over-Year Comparison

	2023	2022	Change
Revenue	$621,098	$678,100	-0.1%
Expenses	$494,708	$673,572	-0.3%
Net Income	$126,390	$4,528	+26.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

$67,406

Key Employees

$133,172

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RHONDA YOUNG	DIRECTOR	40.00	Director Highest	$67,406	$0	$67,406
CORRIE DRUMMOND	COMMUNITY ENGAGEMENT COORDINA	40.00	Key Emp	$55,000	$0	$55,000
HARRIETT CLEVELAND	OFFICE MANAGER	40.00	Key Emp	$23,822	$0	$23,822
CLARA BENSON	VIRTUAL ASSISTANT	40.00	Key Emp	$22,125	$0	$22,125
TAMARA DAVIS	TREASURER	40.00	Key Emp	$21,000	$0	$21,000
JOYCE BREWTON	NURSE	2.00	Key Emp	$8,820	$0	$8,820
JENNIFER GALLAGHER	NURSE	2.00	Key Emp	$2,405	$0	$2,405

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$621,098	$494,708	$142,836	$126,390
2022	$678,100	$673,572	$16,511	$4,528
2021	$207,334	$196,071	$11,983	$11,263
2020	$120,887	$138,226	$720	$-17,339
2019	$209,919	$227,592	$18,059	$-17,673

LOUVENIA D BARKSDALE SICKLE CELL ANEMIA FOUNDATIO